This inventor holds 1 USPTO granted patent. Top assignee: Florida International University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Pulmonary Health by Hitendra S Chand
Introduction
Hitendra S Chand is a notable inventor based in Doral, Florida. He has made significant contributions to the field of pulmonary health through his innovative research and patents. His work focuses on addressing pulmonary diseases, which are a major health concern worldwide.
Latest Patents
Hitendra S Chand holds a patent titled "Long noncoding RNAs in pulmonary airway inflammation." This invention provides methods, assays, and products for preventing and/or treating pulmonary diseases. The patent outlines methods for identifying inhibitors of long noncoding RNAs (lncRNAs), pharmaceutical compositions comprising such inhibitors, and methods for using these inhibitors to prevent and/or treat pulmonary airway inflammation. Additionally, the invention develops novel strategies to modulate the mucous response for preventing, intervening, diagnosing, and treating conditions such as asthma, chronic obstructive pulmonary diseases (COPD), and chronic mucus hypersecretion (CMH) pathogenesis.
Career Highlights
Hitendra S Chand is affiliated with Florida International University, where he conducts his research and contributes to advancements in medical science. His work has garnered attention for its potential impact on improving treatment options for patients suffering from pulmonary conditions.
Collaborations
One of his notable collaborators is Madhavan Nair, with whom he has worked on various research initiatives aimed at enhancing understanding and treatment of pulmonary diseases.
Conclusion
Hitendra S Chand's innovative work in the field of pulmonary health exemplifies the importance of research and development in addressing critical health issues. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
